Lupus Atherosclerosis Prevention Study (LAPS) von Petri, M A, Kiani, A N, Post, W, Christopher-Stine, L, Magder, L S

Volltext

Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus von Wallace, DJ, Navarra, S, Petri, MA, Gallacher, A, Thomas, M, Furie, R, Levy, RA, van Vollenhoven, RF, Cooper, S, Zhong, ZJ, Freimuth, W, Cervera, R

Volltext

Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes von Zhang, Z, Song, L, Maurer, K, Petri, M A, Sullivan, K E

Volltext

The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics Classification criteria for systemic lupus erythematosus in two multiethnic cohorts:... von Pons-Estel, GJ, Wojdyla, D, McGwin, G, Magder, LS, Petri, MA, Pons-Estel, BA, Alarcón, GS

Volltext

Oral vaccination of piglets against Mycoplasma hyopneumoniae using silica SBA-15 as an adjuvant effectively reduced consolidation lung lesions at slaughter von Mechler-Dreibi, Marina L., Almeida, Henrique M. S., Sonalio, Karina, Martines, Mariela A. C., Petri, Fernando A. M., Zambotti, Beatriz B., Ferreira, Marcela M., Storino, Gabriel Y., Martins, Tereza S., Montassier, Hélio J., Sant’Anna, Osvaldo A., Fantini, Márcia C. A., de Oliveira, Luís Guilherme

Volltext

Oral candidiasis in systemic lupus erythematosus von Fangtham, M, Magder, LS, Petri, MA

Volltext

Use of Nanostructured Silica SBA-15 as an Oral Vaccine Adjuvant to Control Mycoplasma hyopneumoniae in Swine Production von Storino, Gabriel Y, Petri, Fernando A M, Mechler-Dreibi, Marina L, Aguiar, Gabriel A, Toledo, Leonardo T, Arruda, Laíza P, Malcher, Clarisse S, Martins, Tereza S, Montassier, Hélio J, Sant'Anna, Osvaldo A, Fantini, Márcia C A, de Oliveira, Luís Guilherme

Volltext

A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus,... von Furie, R A, Leon, G, Thomas, M, Petri, M A, Chu, A D, Hislop, C, Martin, R S, Scheinberg, M A

Volltext

Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod von Petri, M A, Martin, R S, Scheinberg, M A, Furie, R A

Volltext

Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus von Pejchinovski, M, Siwy, J, Mullen, W, Mischak, H, Petri, M A, Burkly, L C, Wei, R

Volltext

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response von van Vollenhoven, Ronald F, Petri, Michelle A, Cervera, Ricard, Roth, David A, Ji, Beulah N, Kleoudis, Christi S, Zhong, Z John, Freimuth, William

Volltext

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial von Navarra, Sandra V, MD, Guzmán, Renato M, MD, Gallacher, Alberto E, MD, Hall, Stephen, MD, Levy, Roger A, MD, Jimenez, Renato E, MD, Li, Edmund K-M, MD, Thomas, Mathew, MD, Kim, Ho-Youn, MD, León, Manuel G, MD, Tanasescu, Coman, MD, Nasonov, Eugeny, MD, Lan, Joung-Liang, MD, Pineda, Lilia, MD, Zhong, Z John, PhD, Freimuth, William, MD, Petri, Michelle A, MD

Volltext

Detection of anti–Mycoplasma hyopneumoniae antibodies in backyard pigs in the state of Paraná, Brazil von Lima, Ana C. A., Braga, Eduarda R., Panneitz, Ana K., Petri, Fernando A. M., Castro, João H. T., Dias, Rafael Gonçalves, de Oliveira, Luís G.

Volltext

FRI0293 Validation of the revised selena flare index in systemic lupus erythematosus von Petri, M. A., Merrill, J. T., Maciuca, R., Davis, J. C., Kennedy, W.

Volltext

Efficacy evaluation of a novel oral silica-based vaccine in inducing mucosal immunity against Mycoplasma hyopneumoniae von Ferreira, Geovana C., Sanches, Thainara V.C., Mechler-Dreibi, Marina L., Almeida, Henrique M.S., Storino, Gabriel Y., Sonalio, Karina, Petri, Fernando A.M., Martins, Tereza S., Cides da Silva, Luís Carlos, Montassier, Hélio J., Sant'Anna, Osvaldo A., Fantini, Márcia C.A., de Oliveira, Luís Guilherme

Volltext

Genetic associations of LYN with systemic lupus erythematosus von Lu, R, Vidal, G S, Kelly, J A, Delgado-vega, A M, Howard, X K, Macwana, S R, Dominguez, N, Klein, W, Burrell, C, Harley, I T, Kaufman, K M, Bruner, G R, Moser, K L, Gaffney, P M, Gilkeson, G S, Wakeland, E K, Li, Q-z, Langefeld, C D, Marion, M C, Divers, J, Alarcón, G S, Brown, E E, Kimberly, R P, Edberg, J C, Ramsey-goldman, R, Reveille, J D, Mcgwin, G, Vilá, L M, Petri, M A, Bae, S-c, Cho, S-k, Bang, S-y, Kim, I, Choi, C B, Martin, J, Vyse, T J, Merrill, J T, Harley, J B, Alarcón-riquelme, M E, Nath, S K, James, J A, Guthridge, J M

Volltext

Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients von Asherson, R A, Cervera, R, Piette, J C, Shoenfeld, Y, Espinosa, G, Petri, M A, Lim, E, Lau, T C, Gurjal, A, Jedryka-Góral, A, Chwalinska-Sadowska, H, Dibner, R J, Rojas-Rodríguez, J, García-Carrasco, M, Grandone, J T, Parke, A L, Barbosa, P, Vasconcelos, C, Ramos-Casals, M, Font, J, Ingelmo, M

Volltext

OP0129 Effects of Blisibimod, an Inhibitor of B-Cell Activating Factor, on Markers of Renal Disease in Patients with SLE von Furie, R., Scheinberg, M., Leon, G., Ramiterre, E. B., Thomas, M., Chu, A. D., Hislop, C., Martin, R. S., Petri, M. A.

Volltext

OP0116 Effects of Blisibimod, a Subcutaneous Inhibitor of B Cell Activating Factor, in Patients with SLE von Furie, R., Scheinberg, M., Leon, G., Ramiterre, E. B., Thomas, M., Chu, A. D., Hislop, C., Martin, R. S., Petri, M. A.

Volltext

THU0283 Two Year Follow-Up on Biologics Use in 13 Centers - Data from the International Registry for Biologics in SLE (IRBIS) von van Vollenhoven, R., Mild, M., Jacobsen, S., Wallace, D. J., Hanley, J. G., Petri, M. A., Bernatsky, S. R., Bae, S.-C., Ramos-Casals, M., Garcia-Hernandez, F., Ayala-Guiterrez, M. D. M., Ramsey-Goldman, R., Doria, A., Mosca, M.

Volltext